1st Quarter - Amendment

AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY for AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY

Firm
Client
Income
—
Expenses
$200,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 22, 2019 $170,000 Replaced
1st Quarter - Amendment (this page) Apr 22, 2019 $200,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Coalition letter to the Office of the U.S. Trade Representative (USTR) regarding tobacco control efforts in the U.S.-United Kingdom Trade Agreement, requesting that any agreement provide the protections necessary to enable both countries to adopt public health measures to protect their citizens from the death and disease caused by tobacco products without facing the risk of litigation by tobacco companies.

LobbyistCovered position, as disclosed
MAURA FARRELL —
KARL MELTON —
AMELIA SUERMANN —
JOY L TRIMMER —

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE; Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR)

Medicare/Medicaid MMM

Issues pertaining to health information technology and electronic health records; in general. Coalition letter to CMS Administrator urging CMS to provide guidance to Medicare Advantage plans on prior authorization through its 2020 Call Letter. Coalition letter addressed to the Chairman and Ranking Member of the U.S. House Committee on Ways and Means regarding surprise out-of-network bills. Issues pertaining to surprise out-of-network bills; in general. Coalition letter addressed to the Director of the Office for Civil Rights (OCR) within the Dept. of Health and Human Services (HHS) regarding a RFIon "Modifying HIPPAA Rules to Improve Coordinated Care." Issues related to prior authorization, in general. Issues pertaining to the Early Detection and Intervention (EHDI) program, in general. Issues related to hearing healthcare; in general. Issues pertaining to scope of practice; in general.

LobbyistCovered position, as disclosed
MAURA FARRELL —
KARL MELTON —
AMELIA SUERMANN —
JOY L TRIMMER —

Contacted: Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Medicare Payment Advisory Commission (MedPAC)

Health Issues HCR

Issues pertaining to health information technology and electronic health records (EHR); in general. Coalition comment letter to the Office of the National Coordinator (ONC)for Health Information Technology at the Dept. of Health and Human Services (HHS) regarding the draft Strategy on Reducing Regulatory and Administrative Burden Relating to the Use of Health IT and EHR. Coalition letter to Administrator of the Maternal and Child Health Bureau within the Health Resources and Services Administration (HRSA)requesting a meeting to discuss issues around the Early Hearing and Detection Intervention (EHDI) program. Coalition letter addressed to the Chairman and Ranking Member of the U.S. House Committee on Ways and Means regarding surprise out-of-network bills. Issues pertaining to surprise out of network bills, in general. Issues pertaining to Language Equality and Acquisition for Deaf Kids (LEAD-K) and parent choice; in general. Issues related to hearing healthcare; in general. Federal "Truth in Advertising" Legislation; in general. Issues pertaining to scope of practice; in general. H.Res.147, Expressing Support for the Designation of March 3, 2019, as World Hearing Day. Issues pertaining to Graduate Medical Education; in general.

LobbyistCovered position, as disclosed
MAURA FARRELL —
KARL MELTON —
AMELIA SUERMANN —
JOY L TRIMMER —

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Medicare Payment Advisory Commission (MedPAC); SENATE; Food & Drug Administration (FDA)

Bills named: H.Res. 147 (116th)

Budget/Appropriations BUD

Coalition letter addressed to the Chair and Ranking Member of the U.S. House of Representatives Appropriations Subcommittee on Labor, Health,and Human Services, Education, and Related Agencies requesting $460 million in budget authority for the Agency for Healthcare Research and Quality (AHRQ). Coalition letter addressed to the Chair and Ranking Member of the U.S. Senate Appropriations Subcommittee on Labor, Health, and Human Services,Education, and Related Agencies requesting $460 million in budget authority for the Agency for Healthcare Research and Quality (AHRQ). Coalition letter addressed to the Chair and Ranking Member of the U.S. House Appropriations Subcommittee on Labor, Health, and Human Services,Education, and Related Agencies urging an increase of $100 million (for a total of $310 million) in funding for the Centers for Disease Control and Prevention (CDC) Office on Smoking and Health (OSH). Coalition letter addressed to the Chair and Ranking Member of the U.S. Senate Appropriations Subcommittee on Labor, Health, and Human Services,Education, and Related Agencies urging an increase of $100 million (for a total of $310 million) in funding for the Centers for Disease Control and Prevention (CDC) Office on Smoking and Health (OSH). Coalition letter addressed to the Chairman and Ranking Member of the U.S. Senate Subcommittee on Agriculture, Rural Development, Food and Drug, and Related Agencies urging approval of the authorized level of user fees for the Food and Drug Administration (FDA) to oversee tobacco products. Coalition letter addressed to the Chairman and Ranking Member of the U.S. House Subcommittee on Agriculture, Rural Development, Food and Drug, and Related Agencies urging approval of the authorized level of user fees for the Food and Drug Administration (FDA) to oversee tobacco products.

LobbyistCovered position, as disclosed
MAURA FARRELL —
KARL MELTON —
AMELIA SUERMANN —
JOY L TRIMMER —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS)

Tobacco TOB

Coalition letter to the Office of the U.S. Trade Representative (USTR) regarding tobacco control efforts in the U.S.-United Kingdom Trade Agreement, requesting that any agreement provide the protections necessary to enable both countries to adopt public health measures to protect their citizens from the death and disease caused by tobacco products without facing the risk of litigation by tobacco companies. Coalition letter addressed to the Chair and Ranking Member of the U.S. House Appropriations Subcommittee on Labor, Health, and Human Services,Education, and Related Agencies urging an increase of $100 million (for a total of $310 million) in funding for the Centers for Disease Control and Prevention (CDC) Office on Smoking and Health (OSH). Coalition letter addressed to the Chair and Ranking Member of the U.S. Senate Appropriations Subcommittee on Labor, Health, and Human Services,Education, and Related Agencies urging an increase of $100 million (for a total of $310 million) in funding for the Centers for Disease Control and Prevention (CDC) Office on Smoking and Health (OSH). Coalition letter addressed to the Chairman and Ranking Member of the U.S. Senate Subcommittee on Agriculture, Rural Development, Food and Drug, and Related Agencies urging approval of the authorized level of user fees for the Food and Drug Administration (FDA) to oversee tobacco products. Coalition letter addressed to the Chairman and Ranking Member of the U.S. House Subcommittee on Agriculture, Rural Development, Food and Drug, and Related Agencies urging approval of the authorized level of user fees for the Food and Drug Administration (FDA) to oversee tobacco products.

LobbyistCovered position, as disclosed
MAURA FARRELL —
KARL MELTON —
AMELIA SUERMANN —
JOY L TRIMMER —

Contacted: SENATE; Medicare Payment Advisory Commission (MedPAC); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.